An analysis of nearly 300 recently identified human SARS-CoV-2 antibodies uncovered a gene frequently used in antibodies that most effectively target the virus. The results contribute to growing structural insight that will be needed for successful vaccine development against SARS-CoV-2.
As the global COVID-19 pandemic continues, multiple vaccine candidates have entered clinical trials. Yet, the molecular features that contribute to the most effective antibody response remain unclear.
The spike protein of SARS-CoV-2 uses its receptor binding domain (RBD) to infect the host receptor, ACE2, on human cells. Antibodies that could target RBD and block binding to ACE2 are highly sought, and a number have been discovered.
The researchers compiled a list of 294 such RBD-targeting antibodies. By analyzing them, they found that a gene in the IGHV gene family, known as IGHV3-53, is the most frequently used IGHV gene for targeting the RBD of the virus spike protein. IGHV3-53 antibodies, the authors say, not only have lower mutation rates but are also more potent.
By studying the crystal structures of two IGHV3-53 antibodies bound to the RBD with or without Fab CR3022, at 2.33 to 3.20 Å resolution revealed that the germline-encoded residues dominate recognition of the ACE2 binding site.. This binding mode limits the IGHV3-53 antibodies to short CDR H3 loops, but accommodates light-chain diversity. These IGHV3-53 antibodies show minimal affinity maturation and high potency, which is promising for vaccine design.
This detailed insight into IGHV-53 neutralizing antibodies should facilitate design of vaccine antigens that elicit this type of neutralizing antibody response, the authors say. "As IGHV3-53 is found at a reasonable frequency in healthy individuals, this particular antibody response could be commonly elicited during vaccination," they write.
https://science.sciencemag.org/content/early/2020/07/10/science.abd2321
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fstructural-basis-of-a&filter=22
A Gene in SARS-CoV-2 Antibody to Target the Virus Protein Identified!
- 1,089 views
- Added
Edited
Latest News
Why young kids don't get se…
By newseditor
Posted 04 Dec
Phosphatidylinositol 3,5-bi…
By newseditor
Posted 04 Dec
Probiotic-guided CAR-T cell…
By newseditor
Posted 04 Dec
Cell atlases of the human b…
By newseditor
Posted 04 Dec
A sperm-specific transporte…
By newseditor
Posted 02 Dec
Other Top Stories
Bio-mimicry method for preparing and labeling stem cells
Read more
Mice with hyper-long telomeres created!
Read more
Red blood cells from skin fibroblasts!
Read more
New techniques to assess the fate of stem cells in vivo
Read more
cAMP signaling in the generation of hematopoietic stem cells
Read more
Protocols
Cheap, cost-effective, and…
By newseditor
Posted 03 Dec
Temporally multiplexed imag…
By newseditor
Posted 02 Dec
Efficient elimination of ME…
By newseditor
Posted 01 Dec
Personalized drug screening…
By newseditor
Posted 30 Nov
Multi-chamber cardioids unr…
By newseditor
Posted 29 Nov
Publications
Toward low-cost gene therap…
By newseditor
Posted 04 Dec
The bidirectional immune cr…
By newseditor
Posted 04 Dec
Leveraging human immune org…
By newseditor
Posted 04 Dec
Single-cell long-read seque…
By newseditor
Posted 04 Dec
Synapse-specific burst codi…
By newseditor
Posted 04 Dec
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar